CHESS Health creates innovative solutions designed at the intersection of science, technology, and recovery.
Founded in 2014 by nationally recognized substance abuse researcher Dr. Dave Gustafson, CHESS developed A-CHESS- the leading evidence-based relapse prevention technology. By integrating A-CHESS into treatment plans, clinicians, case managers and coaches can best support those in recovery with access to predictive relapse analytics, condition-specific content and access to live support, reducing relapse by 50 percent while decreasing costs and saving lives. A leader in the mHealth space, the A-CHESS platform received recognition from the Substance Abuse and Mental Health Services Administration’s National Registry of Evidence-based Programs and Practices (NREPP), the Journal of Substance Abuse and the Surgeon General.